Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Adamis Pharma Forms Agreement With Allergan | Contract Pharma

What are you searching for?

Sign in
Breaking News

Adamis Pharma Forms Agreement With Allergan

Watson Labs to commercialize Epinephrine Pre-Filled Syringe

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Adamis Pharmaceuticals has entered into a licensing agreement with Allergan’s wholly owned subsidiary, Watson Laboratories, to commercialize Adamis’ Epinephrine Pre-filled Syringe (PFS) product candidate for the emergency treatment of anaphylaxis.

Watson will obtain commercial rights for the U.S. in exchange for an upfront fee and potential regulatory and performance based milestone payments totaling up to $32.5 million. Additionally, Watson will pay double-digit royalties to Adamis based on income from future sales of the PFS in the U.S. Adamis retains rights to commercialize the PFS in the rest of the world.

“There is significant demand in the market for an alternative to the high-cost epinephrine auto-injectors,” said Dennis Carlo, president and chief executive officer, Adamis. “We feel that Allergan, through its planned merger with Teva, is the ideal partner to market our epinephrine PFS in the U.S. and by doing so, maximize the value of the product for our shareholders.”

“The epinephrine pre-filled syringe offers payers a cost effective option that can be utilized in specific treatment settings including hospitals and clinics, and will have applications with select patient populations,” said Andy Boyer, president of U.S. generic sales and marketing, Allergan.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters